Drugmakers’ Price Fight Draws Amicus Support in Third Circuit

Bristol Myers Squibb Co., and Johnson & Johnson received a flood of support in their lawsuits seeking to scuttle a government drug price-setting program as various amicus briefs were filed in their favor at the Third Circuit.

At least 15 amicus briefs were filed late last week to defend the pharmaceutical giants in their lawsuits challenging the Biden administration’s Medicare Drug Price Negotiation Program, a signature Inflation Reduction Act plan that allows the government to set prices on some of the costliest drugs Medicare covers.

The two drugmakers in their respective cases have been battling in court with the ...